About this raise
EPR-Technologies, with a valuation of $65 million, is raising funds on StartEngine. It is a biomedical company working on using emergency preservation and resuscitation to induce rapid profound hypothermia. The technology of EPR-Technologies will help to cool the body down and bring it to a stage in which no oxygen delivery is required for over three hours. EPR-Technologies’ solution is currently the only FDA-approved clinical trial for rapid profound hypothermia. Lyn Yaffe and Xianren Wu founded EPR-Technologies in June 2006. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for clinical trials, filing patents, and growth.
Investment Overview
Invested : $71,256
Deal Terms
Total Commitments
- Platform
- StartEngine
- Start Date
- 03/01/2022
- Close Date
- 06/29/2022
$10,000
$1,070,000
$200
Equity - Preferred
Growth Stage
RegCF
$0.50
$65,000,000
Company & Team
Company
- Year Founded
- 2006
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.